Scott B. Ullem has sold EW and made no open-market buys since Mar 2018
CVP, CFO at Edwards Lifesciences Corporation
SEC CIK 0001446989 · Filings on SEC.gov ↗
Every filing
36 filings since Mar 2018, newest first
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
Edwards Lifesciences Corp
CVP, CFO
About Scott B. Ullem
Scott B. Ullem is a Corporate Vice President and Chief Financial Officer (CFO) at Edwards Lifesciences Corporation (NYSE: EW), a position he has held since January 2014.( In this role, he oversees finance as well as information technology, information security, risk management, indirect sourcing, and corporate services.( Ullem recently engaged in insider trading at Edwards Lifesciences and has announced his plan to step down by mid-2026, transitioning to an advisory role thereafter.(
Prior to Edwards, Ullem served as CFO and business unit leader at Bemis Company, Inc. from 2010 to 2013, and spent 17 years in investment banking as Managing Director at Goldman Sachs and Bank of America.( He holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts in Political Science from DePauw University.( Ullem serves on the boards of directors at Illumina, egnite Health, and Berry Global, Inc., where he is on the Compensation and Audit Committees, and is a Henry Crown Fellow at the Aspen Institute.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.